Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1

Status

Completed 21Recruiting 20Active not recruiting 18Terminated 8Withdrawn 4Unknown 3Suspended 1

Sponsor Class

OTHER_GOV 1OTHER 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 47Gastrointestinal 32Dermatologic 21Genitourinary 17Breast 16Gynecologic 15Head & Neck 14Other solid neoplasm 8Lymphoid 7Tumor-Agnostic 4CNS 4Sarcoma 3NET 1Endocrine 1

Conditions

Uterine Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Sarcoma, Kaposi 1Sarcoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Melanoma 1Lung Neoplasms 1Kidney Neoplasms 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Esophageal Neoplasms 1Disease Progression 1Colonic Neoplasms 1Carcinoma 1Breast Neoplasms 1

Interventions

Doxorubicin 25Radiotherapy 16apatinib 15Cyclophosphamide 15Ifosfamide 13anlotinib 12camrelizumab 10Temozolomide 9Imatinib Mesylate 9Vincristine 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Methotrexate 7Drug Therapy 7Dactinomycin 5Blood Specimen Collection 5fludarabine phosphate 4Paclitaxel 4Immune Checkpoint Inhibitors 4Etoposide 4Docetaxel 4Carboplatin 4toripalimab 3pembrolizumab 3Trabectedin 3Topotecan 3Surveys and Questionnaires 3Radiation Dose Hypofractionation 3Nivolumab 3Melphalan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × pembrolizumab × Sarcoma × Clear all
NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Kineta Inc.

Phase 1/2 Unknown
314 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT03469804 2019-10-21

KAPKEY

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown
17 enrolled
Sarcoma

Sarcoma, Kaposi, Disease Progression

NCT02430363 2016-02-24

Evaluation Of The Treatment Effectiveness Of Glioblastoma / Gliosarcoma Through The Suppression Of The PI3K/Akt Pathway In Compared With MK-3475

Medical Research Council

Phase 1/2 Unknown
58 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡